Sex-specific pathways in early cardiac response to pressure overload in mice

Author(s): Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, et al.

Abstract

Pressure overload (PO) first causes cardiac hypertrophy and then heart failure (HF), which are associated with sex differences in cardiac morphology and function. We aimed to identify genes that may cause HF-related sex differences. We used a transverse aortic constriction (TAC) mouse model leading to hypertrophy without sex differences in cardiac function after 2 weeks, but with sex differences in hypertrophy 6 and 9 weeks after TAC. Cardiac gene expression was analyzed 2 weeks after surgery. Deregulated genes were classified into functional gene ontology (GO) categories and used for pathway analysis. Classical marker genes of hypertrophy were similarly upregulated in both sexes (alpha-actin, ANP, BNP, CTGF). Thirty-five genes controlling mitochondrial function (PGC-1, cytochrome oxidase, carnitine palmitoyl transferase, acyl-CoA dehydrogenase, pyruvate dehydrogenase kinase) had lower expression in males compared to females after TAC. Genes encoding ribosomal proteins and genes associated with extracellular matrix remodeling exhibited relative higher expression in males (collagen 3, matrix metalloproteinase 2, TIMP2, and TGFbeta2, all about twofold) after TAC. We confirmed 87% of the gene expression by real-time polymerase chain reaction. By GO classification, female-specific genes were related to mitochondria and metabolism and males to matrix and biosynthesis. Promoter studies confirmed the upregulation of PGC-1 by E2. Less downregulation of metabolic genes in female hearts and increased protein synthesis capacity and deregulation of matrix remodeling in male hearts characterize the sex-specific early response to PO. These differences could contribute to subsequent sex differences in cardiac function and HF.

Similar Articles

Omics meets hypothesisdriven research

Author(s): Ruegg C, Tissot JD, Farmer P, Mariotti A

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Author(s): Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, et al.

Outcome of heart failure with preserved ejection fraction in a population-based study

Author(s): Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, et al.

Global cardiovascular reserve dysfunction in heart failure with preserved ejection fraction

Author(s): Borlaug BA, Olson TP, Lam CS, Flood KS, Lerman A, et al.

Filling pressures and collagen metabolism in hypertensive patients with heart failure and normal ejection fraction

Author(s): Gonzalez A, Lopez B, Querejeta R, Zubillaga E, Echeverria T, et al.

Inflammatory pathways in patients with heart failure and preserved ejection fraction

Author(s): Niethammer M, Sieber M, von Haehling S, Anker SD, Munzel T, et al.

Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey

Author(s): Lenzen MJ, Scholte op Reimer WJ, Boersma E, Vantrimpont PJ, Follath F, et al.

The perindopril in elderly people with chronic heart failure (PEP-CHF) study

Author(s): Cleland JG, Tendera M, Adamus J, Freemantle N, Polonski L, et al.

Proteomic analysis of left ventricular diastolic dysfunction hearts in renovascular hypertensive rats

Author(s): Junhong W, Jing Y, Jizheng M, Shushu Z, Xiangjian C, et al.

Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness

Author(s): Levy D, Larson MG, Benjamin EJ, Newton-Cheh C, Wang TJ, et al.

Genome-wide association study identifies eight loci associated with blood pressure

Author(s): Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, et al.

Genome-wide association study of blood pressure and hypertension

Author(s): Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al.

Initial sequencing and analysis of the human genome

Author(s): Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, et al.

A second generation human haplotype map of over 3

Author(s): Frazer KA, Ballinger DG, Cox DR, Hinds DA, Stuve LL, et al.

Plasma cytokine parameters and mortality in patients with chronic heart failure

Author(s): Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, et al.

Colocalization of myocardial fibrosis and inflammatory cells in rats

Author(s): Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, et al.

Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction

Author(s): Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Sex-dependent differences in left ventricular function and structure in chronic pressure overload

Author(s): Villari B, Campbell SE, Schneider J, Vassalli G, Chiariello M, et al.

Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs

Author(s): Kruger M, Kotter S, Grutzner A, Lang P, Andresen C, et al.

Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium

Author(s): Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, et al.

PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness

Author(s): Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, et al.

Role of extracellular matrix in vascular remodeling of hypertension

Author(s): riones AM, Arribas SM, Salaices M

Left ventricular diastolic parameters in 288 normal subjects from 20 to 80 years old

Author(s): Mantero A, Gentile F, Gualtierotti C, Azzollini M, Barbier P, et al.

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

Author(s): Silberman GA, Fan TH, Liu H, Jiao Z, Xiao HD, et al.

Sex Differences in Sympathetic Neural-Hemodynamic Balance: implications for human blood pressure regulation

Author(s): Hart EC, Charkoudian N, Wallin GG, Curry TB, Eisenach JH, et al.

Cytoscape: a software environment for integrated models of biomolecular interaction networks

Author(s): Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, et al.